Search Login Register
lumiracoxib
(prexige)
Summary
Description:
a COX-2 inhibitor
Also Known As:
prexige; COX 189; COX-189; Novartis brand of lumiracoxib; 2-(2-((2-chloro-6-fluoro-phenyl)amino)-5-methyl-phenyl)acetic acid
Networked: 106
relevant articles (29 outcomes,
51 trials/studies)
for this Bio-Agent
Key Diseases for which lumiracoxib is
Relevant
-
Pain (Aches)
:
14 outcomes 12 studies in 37 results
-
Osteoarthritis
:
10 outcomes 20 studies in 43 results
-
Rheumatoid Arthritis
:
5 outcomes 5 studies in 17 results
-
Arthritis (Polyarthritis)
:
2 outcomes 10 studies in 13 results
-
Tension-Type Headache (Tension Headache)
:
2 outcomes 1 study in 2 results
Show All >>
Drugs Related to lumiracoxib
-
celecoxib (Celebrex)
-
Ibuprofen (Motrin)
-
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
-
Naproxen (Naprosyn)
-
lumiracoxib (prexige)
-
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
-
Aspirin (Acetylsalicylic Acid)
-
rofecoxib (Vioxx)
-
etoricoxib
-
Cyclooxygenase 2 (Cyclooxygenase-2)
Show All >>
Therapies Related to lumiracoxib
-
Analgesia
-
Lasers (Laser)
-
Stents
-
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
-
Root Planing
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.